119 related articles for article (PubMed ID: 6209058)
1. Demonstration of tumor-associated immunoglobulin G isolated from immune complexes in ascitic fluid of ovarian cancer.
Silburn PA; Khoo SK; Hill R; Daunter B; Mackay EV
Diagn Immunol; 1984; 2(1):30-5. PubMed ID: 6209058
[TBL] [Abstract][Full Text] [Related]
2. Types of immune complexes in the ascitic fluid of women with carcinoma of the ovary.
Silburn PA; Khoo SK; Daunter B; Hill R; Roberts TK; Mackay EV
Int Arch Allergy Appl Immunol; 1983; 71(3):219-23. PubMed ID: 6602096
[TBL] [Abstract][Full Text] [Related]
3. The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
Qian HN; Feng J; Fu TY
Gynecol Oncol; 1985 Jan; 20(1):100-8. PubMed ID: 3965372
[TBL] [Abstract][Full Text] [Related]
4. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
Rao GS; Hanjani P
Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer-associated antibodies recovered from ascites: their use for the isolation of ovarian cancer-associated antigen to produce monoclonal antibodies.
Giancotti FR; Dorsett BH; Qian HN; Cronin WJ; Barber HR; Ioachim HL
Gynecol Oncol; 1990 Apr; 37(1):24-8. PubMed ID: 2182406
[TBL] [Abstract][Full Text] [Related]
6. Ovarian tumor antigens: preliminary histological investigation.
Daunter B; Jaa-Kwee D; Miklosi S; Wright G
Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
[TBL] [Abstract][Full Text] [Related]
7. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity.
Kutteh WH; Doellgast GJ
J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453
[TBL] [Abstract][Full Text] [Related]
8. Isolation of tumour-associated immunoglobulins from ascitic fluid.
Hill R; Daunter B; Khoo SK; MacKay EV
Br J Cancer; 1978 Jul; 38(1):154-7. PubMed ID: 687514
[No Abstract] [Full Text] [Related]
9. Immunoglobulins reactive to carcinoembryonic antigen and their relationship to the antigen in malignant ascitic fluid of ovarian carcinoma.
Hill R; Khoo SK; Daunter B; Silburn PA; Mackay EV
Int J Cancer; 1982 Nov; 30(5):587-92. PubMed ID: 7152721
[TBL] [Abstract][Full Text] [Related]
10. Detection of human ovarian tumor-associated antigens by sandwich enzyme immunoassay.
Rao GS; Hanjani P
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):423-8. PubMed ID: 3279355
[TBL] [Abstract][Full Text] [Related]
11. Immune complexes in ovarian cancer: association between IgM class complexes and antinuclear autoantibodies in ascitic fluid.
Silburn PA; Neil JC; Khoo SK; Daunter B; Hill R; Collins RJ; Mackay EV
Int Arch Allergy Appl Immunol; 1984; 74(1):63-6. PubMed ID: 6608501
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer: immunologic diagnosis and therapy.
Barber HR; Dorsett B
Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
[No Abstract] [Full Text] [Related]
13. [Binding of IgG and IgM class antibodies from the serum of patients with ovarian carcinoma to malignant and normal ovaries].
Stankus P; Gazárek F
Cesk Gynekol; 1983 Jun; 48(5):332-8. PubMed ID: 6352065
[No Abstract] [Full Text] [Related]
14. [Production of carcinoembryonic antigen by a benign cystadenoma of the ovary. Association with gelatinous disease of the peritoneum].
Pagé M; Bertrand G; Dalifard I; Ronceray J; Daver A; Esperandieu O; Saint-André JP
Presse Med; 1984 Feb; 13(8):503. PubMed ID: 6230636
[No Abstract] [Full Text] [Related]
15. Possibility of immunodiagnosis in ovarian cancer.
Chin Med J (Engl); 1978 May; 4(3):185-90. PubMed ID: 98299
[No Abstract] [Full Text] [Related]
16. Carcinoembryonic antigen in ovarian cancer: correlation of concentrations in tumour tissue, cyst fluid, ascitic fluid and peripheral blood.
Khoo SK; Hill R; Daunter B; Mackay EV
Aust N Z J Obstet Gynaecol; 1982 May; 22(2):65-70. PubMed ID: 6958253
[No Abstract] [Full Text] [Related]
17. Nature of carcinoembryonic antigen purified from malignant ascitic fluid of serous cystadenocarcinoma of the ovary.
Hill R; Daunter B; Khoo SK; Mackay EV
Mol Immunol; 1981 Jul; 18(7):647-53. PubMed ID: 7300840
[No Abstract] [Full Text] [Related]
18. [Circulating immune complex of ovarian epithelial carcinoma and its clinical use].
Cui H; Qian HN
Zhonghua Fu Chan Ke Za Zhi; 1987 Jul; 22(4):223-5, 253-4. PubMed ID: 3665670
[No Abstract] [Full Text] [Related]
19. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma.
Harlozinska A; Bar JK; Richter R; Cislo M
Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
